Faecal excretion of ciprofloxacin after a single oral dose and its effect on faecal bacteria in healthy volunteers
- PMID: 2211433
- DOI: 10.1093/jac/26.1.125
Faecal excretion of ciprofloxacin after a single oral dose and its effect on faecal bacteria in healthy volunteers
Abstract
High concentrations of ciprofloxacin have been shown to persist in the faeces of volunteers for several days after a week of oral treatment with this drug, which was also found to have a prolonged effect on aerobic Gram-negative intestinal bacteria. To determine whether a shorter course of ciprofloxacin would have the same prolonged effect, we treated ten healthy adult volunteers with a single oral dose of 750 mg ciprofloxacin and found that this was not followed by any significant changes in the counts of anaerobes or streptococci, but that there was a mean decrease of 2.5 log10 cfu/ml in the counts of faecal Enterobacteriaceae, which lasted for a full week. We attributed this to the persistence of high faecal ciprofloxacin concentrations for several days in all the volunteers. We did not observe any significant increase in the MICs of ciprofloxacin for faecal Enterobacteriaceae, or any faecal overgrowth of staphylococci, fungi, Pseudomonas aeruginosa or Clostridium difficile.
Similar articles
-
Effect of oral spiramycin on the faecal and oral bacteria in human volunteers.J Antimicrob Chemother. 1991 Mar;27(3):355-60. doi: 10.1093/jac/27.3.355. J Antimicrob Chemother. 1991. PMID: 1903789 Clinical Trial.
-
Effect of oral ciprofloxacin on the faecal flora of healthy volunteers.Eur J Clin Microbiol. 1986 Apr;5(2):201-5. doi: 10.1007/BF02013987. Eur J Clin Microbiol. 1986. PMID: 2941281
-
The effect of cefuroxime axetil on the faecal flora of healthy volunteers.J Antimicrob Chemother. 1990 Aug;26(2):261-8. doi: 10.1093/jac/26.2.261. J Antimicrob Chemother. 1990. PMID: 2211457
-
Influence of ciprofloxacin on the colonic microflora in young and elderly volunteers: no impact of the altered drug absorption.Scand J Infect Dis. 1990;22(2):205-8. doi: 10.3109/00365549009037903. Scand J Infect Dis. 1990. PMID: 2356443
-
In vitro activity of ciprofloxacin against gram-positive bacteria. An overview.Am J Med. 1987 Apr 27;82(4A):33-9. Am J Med. 1987. PMID: 3555058 Review.
Cited by
-
Correlation between fecal concentrations of ciprofloxacin and fecal counts of resistant Enterobacteriaceae in piglets treated with ciprofloxacin: toward new means to control the spread of resistance?Antimicrob Agents Chemother. 2012 Sep;56(9):4973-5. doi: 10.1128/AAC.06402-11. Epub 2012 Jul 2. Antimicrob Agents Chemother. 2012. PMID: 22751547 Free PMC article.
-
Use of fluoroquinolones is the single most important risk factor for the high bacterial load in patients with nasal and gastrointestinal colonization by multidrug-resistant Acinetobacter baumannii.Eur J Clin Microbiol Infect Dis. 2015 Dec;34(12):2359-66. doi: 10.1007/s10096-015-2489-4. Epub 2015 Sep 15. Eur J Clin Microbiol Infect Dis. 2015. PMID: 26373714
-
Independent behavior of commensal flora for carriage of fluoroquinolone-resistant bacteria in patients at admission.Antimicrob Agents Chemother. 2010 Dec;54(12):5193-200. doi: 10.1128/AAC.00823-10. Epub 2010 Sep 27. Antimicrob Agents Chemother. 2010. PMID: 20876373 Free PMC article.
-
Eradication of convalescent-phase Salmonella carriage in children with two oral doses of pefloxacin.Eur J Clin Microbiol Infect Dis. 1994 Apr;13(4):307-10. doi: 10.1007/BF01974606. Eur J Clin Microbiol Infect Dis. 1994. PMID: 8070435 Clinical Trial.
-
Ciprofloxacin dosage and emergence of resistance in human commensal bacteria.J Infect Dis. 2009 Aug 1;200(3):390-8. doi: 10.1086/600122. J Infect Dis. 2009. PMID: 19563257 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical